HOME >> BIOLOGY >> NEWS
New Strategy Discerns Early Stages Of HIV Infection, Paving Way For Targeted Study And Therapy

Researchers have devised a strategy for determining how long a person has been infected with HIV. And the finding, said one of the investigators, could revolutionize the approach to understanding early HIV infection, developing appropriate early treatments and estimating the incidence of HIV infection on a national scale.

The multi-institutional finding was reported in the July 1 special issue of JAMA. The general diagnostic approach will also be discussed in a number of sessions at the 12th World AIDS Conference in Geneva next week. The study was conducted by researchers at eight public and private institutions. The new tactic addresses what has been a major obstacle in the study and treatment of patients with HIV infection: the inability to determine how long a person has been infected with the virus, particularly in the early stages of infection.

Diagnosis is made when blood tests indicate that a person either carries the HIV virus or has antibodies to the virus. But these tests do not distinguish infection that occurred 10 days previously from infection that occurred 10 months before. As a result, scientists have not been able to study and tailor treatment to people with the earliest stages of the disease.

The researchers set out to overcome this roadblock. They modified the existing HIV test, called an enzyme immunoassay, to make it less sensitive than the original version. They then administered both tests to 579 people with HIV or AIDS. The result was that some people reacted only to the more sensitive form of the test. And these people, the researchers determined through subsequent study, had a more recent infection.

"This is the first test we've had that sensitively distinguishes patients with the very early stages of HIV from those with more advanced disease," said Margaret Chesney, PhD, a UCSF professor of medicine and co-director of the Center for AIDS Prevention Studies, part of the UCSF AIDS Research Institute (ARI) and a co-aut
'"/>

Contact: Jennifer O'Brien
jobrien@itsa.ucsf.edu
(415) 476-2557
University of California - San Francisco
27-Jun-1998


Page: 1 2 3

Related biology news :

1. Strategy to treat AIDS patients in Africa with less drug, reduced toxicity set for clinical test
2. Dual Control Strategy Assures Accurate Cellular Marching Orders, But A Pathogenic Microbe Can Hijack The System
3. New Gene Therapy Strategy Keeps Muscles Strong In Old Age: Possibilities Seen For Disease Treatment, But Also For Athletic Or Cosmetic Enhancements
4. Novel Two-Antibody Strategy To Fight Cancer Awarded Patent
5. Inter-Element Recombination Between Retrotransposons May Be Strategy For Evolution Of Viruses Like HIV
6. Duke Researchers Call Gene Therapy A Promising Strategy For Sickle Cell Anemia
7. Pitt Researchers Develop Strategy To Use Dendritic Cells To Treat And Prevent Tumors
8. Recombinant Protein Immunizes Mice, Promises New Strategy Against Infection And Cancer
9. Berkeley Lab soil scientist Margaret Torn receives Presidential Early Career Award
10. Early detection hope for eye disease
11. Early clinical treatment can halt progression of Alzheimers disease, UCI researchers find

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/9/2018)... ... November 08, 2018 , ... Boekel Scientific launches a new ... as dry bath incubators are used in laboratories worldwide for controlling and maintaining ... new heating blocks, Boekel Scientific used the same interface design as their recently ...
(Date:11/7/2018)... ... November 07, 2018 , ... NDA Partners Chairman ... professional with extensive experience in clinical trial management, including managing operations and trials ... and Asia, has joined the firm as an Expert Consultant. , Prior ...
(Date:11/6/2018)... ... November 06, 2018 , ... uBiome, the leader in microbial ... at the University of California, San Francisco (UCSF) and Co-President of Chan Zuckerberg Biohub, ... to uBiome since 2013, and we are honored that he is expanding his role ...
Breaking Biology News(10 mins):
(Date:10/31/2018)... ... , ... Rooam , the premier payment platform for the nightlife and ... acquisition of the Tally payment app, the leading payment platform in Chicago that allows ... its market share and increase the number of restaurant and bar locations offered on ...
(Date:10/31/2018)... , ... October 30, 2018 , ... Pippa Rose is a young Labrador retriever. ... year old, Pippa suffered a partial tear to the cruciate ligament in her right knee. ... or go on walks. Kinsley reported that it broke her heart to see Pippa ...
(Date:10/31/2018)... ... October 30, 2018 , ... Today, the National Corn Growers ... of this global competition is to find new and innovative uses of field corn. ... farmers produced 14.6 billion bushels of corn and are on pace to produce the ...
(Date:10/25/2018)... ... October 24, 2018 , ... To prepare for radiological and nuclear emergencies, the ... Argentum Medical, LLC to repurpose its commercial Silverlon ® technology for radiation ... held company has been awarded a three-year, $8.4 million contract with the Biomedical Advanced ...
Breaking Biology Technology:
Cached News: